Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 17;22(1):69.
doi: 10.1186/s40199-014-0069-2.

Isotretinoin-associated Sweet's syndrome: a case report

Affiliations

Isotretinoin-associated Sweet's syndrome: a case report

Jamileh Moghimi et al. Daru. .

Abstract

Objective: Sweet's syndrome (SS) is characterized by various clinical symptoms, physical features, and pathological findings. Although cases of SS are very rare, there has been an increase in the incidence of drug-induced SS. Till date, there have been only few reported cases of isotretinoin-induced SS. In this report, we describe the case of a 19-year-old girl who developed SS after systemic treatment with oral isotretinoin for nodulocystic acne.

Conclusions: The findings of this report emphasize the importance of evaluating isotretinoin as a possible, though uncommon, cause of SS and replacing it with another treatment if its involvement is suspected.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Isotretinoin-associated Sweet’s Syndrome. Erythematous, edematous, painful plaques on suprapubic area (A) and right lower extremity (B).
Figure 2
Figure 2
Isotretinoin-associated Sweet’s Syndrome. Edema of dermis, infiltration of neutrophils and leukocytoclasis, edema of endothelial cells and no vasculitis.

References

    1. Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761–778. doi: 10.1046/j.1365-4362.2003.01891.x. - DOI - PubMed
    1. Neoh CY, Tan AWH, Ng SK. Sweet’s syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007;6(3):480–485. doi: 10.1111/j.1365-2133.2006.07677.x. - DOI - PubMed
    1. Bonamigo RR, Razera F, Olm GS. Neutrophilic dermatoses: part I. An Bras Dermatol. 2011;86(1):11–25. doi: 10.1590/S0365-05962011000100002. - DOI - PubMed
    1. Thompson DF, Montarella KE. Drug-induced Sweet’s syndrome. Ann Pharmacother. 2007;41:802–811. doi: 10.1345/aph.1H563. - DOI - PubMed
    1. Roujeau JC. Neutrophilic drug eruptions. Clin Dermatol. 2000;18:331–337. doi: 10.1016/S0738-081X(99)00124-8. - DOI - PubMed

LinkOut - more resources